Sound Pharmaceuticals Inc — Form D
Sound Pharmaceuticals Inc of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-06. The offering totals $10.4M, of which $8.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-06-06
- Form: D
- Accession: 0001165353-18-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.4M
- Amount sold: $8.4M
- Remaining: $2.0M
- Investors: 5
- Date of first sale: 2018-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313998
Issuer
- Name: Sound Pharmaceuticals Inc
- CIK: 0001165353
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4010 STONE WAY NORTH, SUITE 120, SEATTLE, WA, 98103
- Phone: 206-634-2559
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Joseph Ashley | Director | Seattle, WA |
| David Guyer | Director | Mt. Arlington, NJ |
| Glenn Kawasaki | Director | Seattle, WA |
| Jonathan Kil | Director | Seattle, WA |
| James C Towne | Director | Seattle, WA |
| Jonathan Kil | Executive Officer | Seattle, WA |
| John C Sullivan | Executive Officer | Las Vegas, NV |
| Paul Thompson | Director | Novato, CA |
| Eric Lynch | Director | Birmingham, AL |
| Eric Lynch | Executive Officer | Birmingham, AL |
| James Paul Rickey | Executive Officer | Seattle, WA |
| Glenn Kawasaki | Executive Officer | Seattle, WA |
Other filings by this issuer (4)
More